Lessons from a decade of integrating cancer copy number alterations with gene expression profiles

Briefings in Bioinformatics

Volumn 13, Issue 3, 2012, Pages 305-316

  Huang, Norman ^a   Shah, Parantu K ^a   Li, Cheng ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cancer; Copy number; Data integration; Gene expression; Integrative analysis

Indexed keywords

ALGORITHM; ARTICLE; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; METHODOLOGY; NEOPLASM; STATISTICAL ANALYSIS;

ALGORITHMS; DATA INTERPRETATION, STATISTICAL; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOMICS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84861822799     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbr056     Document Type: Article

References (89)

1. Vogelstein B, Kinzler KW. The Genetic Basis of Human Cancer. New York, USA: McGraw-Hill Professional, 2002.
2. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat Genet 2003; 34:369-76.
3. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-12.
4. Alitalo K, Schwab M, Lin CC, et al. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 1983;80:1707-11.
5. Hinds PW, Dowdy SF, Eaton EN, et al. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994;91:709-13.
6. Wahl GM, Padgett RA, Stark GR. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. J BiolChem 1979;254:8679-89.
7. Schimke RT, Kaufman RJ, Alt FW, Kellems RF. Gene amplification and drug resistance in cultured murine cells. Science 1978;202:1051-5.
8. Koivisto P, Kononen J, Palmberg C, et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997;57:314-9.
9. Gorre ME, Mohammed M, Ellwood K, etal. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001;293:876-80.
10. Li J, Yen C, Liaw D, etal. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-7.
11. Orlow I, Lacombe L, Hannon GJ, et al. Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst 1995;87:1524-9.
12. Nagai MA, Yamamoto L, Salaorni S, et al. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer 1994;11:58-62.
13. Cavenee WK, Dryja TP, Phillips RA, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779-84.
14. Baker SJ, Preisinger AC, Jessup JM, et al. P53 Gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50:7717-22.
15. Ruivenkamp CA, van Wezel T, Zanon C, et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 2002;31:295-300.
16. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006;444: 444-54.
17. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37(Suppl):S11-7.
18. National Cancer Institute. The Cancer Genome Atlas Homepage. http://cancergenome.nih.gov (11 May 2011, date last accessed).
19. Lee H, Kong SW, Park PJ. Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes. Bioinformatics 2008;24:889-96.
20. Monni O, Barlund M, Mousses S, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 2001;98:5711-16.
21. Medvedev P, Stanciu M, Brudno M. Computational methods for discovering structural variation with next-generation sequencing. NatMethods 2009;6:S13-20.
22. van de Wiel MA, Picard F, van Wieringen WN, Ylstra B. Preprocessing and downstream analysis of microarray DNA copy number profiles. Brief Bioinform 2011;12:10-21.
23. Winchester L, Yau C, Ragoussis J. Comparing CNV detection methods for SNP arrays. Brief Funct Genomic Proteomic 2009;8:353-366.
24. Peiffer DA, Le JM, Steemers FJ, et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 2006;16: 1136-48.
25. Staaf J, Lindgren D, Vallon-Christersson J, et al. Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays. Genome Biol 2008;9:R136.
26. Bicciato S, Spinelli R, Zampieri M, et al. A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets. Nucleic Acids Res 2009;37:5057-70.
27. Hyman E, Kauraniemi P, Hautaniemi S, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002;62:6240-5.
28. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. ProcNatl Acad SciUSA 2002;99:12963-8.
29. Phillips JL, Hayward SW, Wang Y, et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 2001;61:8143-9.
30. Jarvinen AK, Autio R, Haapa-Paananen S, et al. Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 2006;25: 6997-7008.
31. Stranger BE, Forrest MS, Dunning M, etal. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007;315:848-53.
32. Wolf M, Mousses S, Hautaniemi S, et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 2004;6:240-7.
33. Masayesva BG, Ha P, Garrett-Mayer E, et al. Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. ProcNatl Acad SciUSA 2004;101:8715-20.
34. Soroceanu L, Kharbanda S, Chen R, et al. Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma. ProcNatl Acad SciUSA 2007;104:3466-71.
35. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006;9:157-73.
36. Adler AS, Lin M, Horlings H, et al. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet 2006;38:421-30.
37. Qin LX. An integrative analysis of microRNA and mRNA expression-a case study. Cancer Inform 2008;6:369-79.
38. Akavia UD, Litvin O, Kim J, et al. An integrated approach to uncover drivers of cancer. Cell 2010;143:1005-17.
39. Sweet-Cordero A, Tseng GC, You H, et al. Comparison of gene expression and DNA copy number changes in a murine model of lung cancer. Genes Chromosomes Cancer 2006;45:338-48.
40. Bergamaschi A, Kim YH, Kwei KA, et al. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Mol Oncol 2008;2:327-39.
41. Woo HG, Park ES, Lee JS, et al. Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res 2009;69:4059-66.
42. Chin K, DeVries S, Fridlyand J, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006;10:529-41.
43. Broet P, Richardson S. Detection of gene copy number changes in CGH microarrays using a spatially correlated mixture model. Bioinformatics 2006;22:911-8.
44. Etemadmoghadam D, deFazio A, Beroukhim R, et al. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res 2009;15:1417-27.
45. Zhang Y, Martens JW, Yu JX, et al. Copy number alterations that predict metastatic capability of human breast cancer. Cancer Res 2009;69:3795-801.
46. Shen R, Olshen AB, Ladanyi M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics 2009;25:2906-12.
47. Kingsley CB, Kuo WL, Polikoff D, et al. Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer. Cancer Inform 2007;2:10-21.
48. Chiang DY, Villanueva A, Hoshida Y, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008;68:6779-88.
49. Beck AH, Lee CH, Witten DM, et al. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene 2010;29:845-54.
50. Ruano Y, Mollejo M, Ribalta T, et al. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer 2006;5:39.
51. Yao J, Weremowicz S, Feng B, et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 2006;66:4065-78.
52. van Wieringen WN, Belien JA, Vosse SJ, et al. ACE-it: a tool for genome-wide integration of gene dosage and RNA expression data. Bioinformatics 2006;22:1919-20.
53. Schafer M, Schwender H, Merk S, et al. Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities. Bioinformatics 2009;25:3228-35.
54. Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. NatRevCancer 2006;6: 924-35.
55. van de Wiel MA, Wieringen WN. CGH regions: dimension reduction for array CGH data with minimal information loss. Cancer Inform 2007;3:55-63.
56. Van Wieringen WN, Van De Wiel MA. Nonparametric testing for DNA copy number induced differential mRNA gene expression. Biometrics 2009;65:19-29.
57. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005;436: 117-22.
58. Chang HY, Sneddon JB, Alizadeh AA, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004;2:E7.
59. Gu W, Choi H, Ghosh D. Global associations between copy number and transcript mRNA microarray data: an empirical study. Cancer Inform 2008;6:17-23.
60. Kotliarov Y, Kotliarova S, Charong N, et al. Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res 2009;69:1596-603.
61. Menezes RX, Boetzer M, Sieswerda M, et al. Integrated analysis of DNA copy number and gene expression microarray data using gene sets. BMC Bioinformatics 2009; 10:203.
62. Berger JA, Hautaniemi S, Mitra SK, Astola J. Jointly analyzing gene expression and copy number data in breast cancer using data reduction models. IEEE/ACMTrans Comput Biol Bioinform 2006;3:2-16.
63. Tsukamoto Y, Uchida T, Karnan S, et al. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 2008;216:471-82.
64. Lipson D, Ben-Dor A, Dehan E, Yakhini Z. Joint analysis of DNA copy numbers and gene expression levels. Algorithms Bioinformatics 2004;3240:135-46.
65. Soneson C, Lilljebjorn H, Fioretos T, Fontes M. Integrative analysis of gene expression and copy number alterations using canonical correlation analysis. BMC Bioinformatics 2010;11:191.
66. Gonzalez I, DeJean S, Martin P, et al. Highlighting relationships between heterogeneous biological data through graphical displays based on regularized canonical correlation analysis. J Biol Syst 2008;17:173-99.
67. Segal E, Shapira M, Regev A, et al. Module networks: Identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 2003;34: 166-76.
68. Tonon G, Wong KK, Maulik G, et al. High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 2005;102:9625-30.
69. Chen W, Salto-Tellez M, Palanisamy N, et al. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes Chromosomes Cancer 2007;46:288-301.
70. Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010;18:11-22.
71. Durig J, Bug S, Klein-Hitpass L, et al. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia 2007;21:2153-63.
72. Myllykangas S, Junnila S, Kokkola A, et al. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Int J Cancer 2008; 123:817-25.
73. Rinaldi A, Kwee I, Taborelli M, et al. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. BrJHaematol 2006;132:303-16.
74. Olejniczak ET, Van Sant C, Anderson MG, et al. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains. Mol Cancer Res 2007;5: 331-9.
75. Chari R, Coe BP, Wedseltoft C, et al. SIGMA2: a system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes. BMC Bioinformatics 2008;9:422.
76. Salari K, Tibshirani R, Pollack JR. DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics 2010;26:414-6.
77. Louhimo R, Hautaniemi S. CNAmet: an R package for integrating copy number, methylation and expression data. Bioinformatics 2011;27:887-8.
78. Peng J, Zhu J, Bergamaschi A, etal. Regularized multivariate regression for identifying master predictors with application to integrative genomics study of breast cancer. AnnApplStat 2010;4:53.
79. Li R, Yerganian G, Duesberg P, etal. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. ProcNatl Acad SciUSA 1997;94:14506-11.
80. Rasnick D, Duesberg PH. How aneuploidy affects metabolic control and causes cancer. BiochemJ 1999;340(Pt 3): 621-30.
81. Marx J. Debate surges over the origins of genomic defects in cancer. Science 2002;297:544-6.
82. Li R, Sonik A, Stindl R, etal. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci USA 2000; 97:3236-41.
83. Duesberg PH. Are cancers dependent on oncogenes or on aneuploidy? Cancer Genet Cytogenet 2003;143:89-91.
84. Shih IM, Zhou W, Goodman SN, et al. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 2001;61:818-22.
85. Zimonjic D, Brooks MW, Popescu N, et al. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 2001;61:8838-44.
86. Lamlum H, Papadopoulou A, Ilyas M, et al. APC mutations are sufficient for the growth of early colorectal adenomas. ProcNatl Acad SciUSA 2000;97:2225-8.
87. Morozova O, Marra MA. Applications of next-generation sequencing technologies in functional genomics. Genomics 2008;92:255-64.
88. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455:1069-75.
89. Parsons DW, Jones S, Zhang X, etal. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321:1807-12.